Creation of a plasma and a Serum pool for use as a negative control in immunological assays

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025947

Enrollment

200

Registered

2023-02-06

Start date

2021-09-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M06.9 D66

Interventions

Group 1: healthy test persons, testing for anti collagen-, anti factor VIII-antibodies and ACPAs

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: no further criteria

Exclusion criteria

Exclusion criteria: known rheumatic disease or coagulation disorder

Design outcomes

Primary

Measure	Time frame
detection of anti-collagen-antibodies, ACPAs, or anti-FVIII-antibodies	—

Secondary

Measure	Time frame
no secondary endpoint	—

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026